Catheter Introducer Sheaths Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Integrated Introducer Sheaths, Separable Introducer Sheaths), By End user (Hospitals & Clinics, Ambulatory Care Centers, Others), By Region and Competition, 2021-2031F

Forecast Period	2027-2031
Market Size (2025)	USD 1.51 Billion
CAGR (2026-2031)	4.26%
Fastest Growing Segment	Integrated Introducer Sheaths
Largest Market	North America
Market Size (2031)	USD 1.94 Billion

Market Overview

The Global Catheter Introducer Sheaths Market will grow from USD 1.51 Billion in 2025 to USD 1.94 Billion by 2031 at a 4.26% CAGR. Catheter introducer sheaths are specialized medical devices designed to establish a secure and haemostatic access point for inserting interventional tools into the vascular system. The primary drivers fueling market growth include the rising global prevalence of cardiovascular diseases and a marked shift toward minimally invasive diagnostic and therapeutic procedures. This increasing demand is further amplified by an aging global population that requires frequent vascular interventions. According to the American Heart Association, in 2024, updated statistics revealed that cardiovascular disease accounted for nearly 20 million deaths globally per year, highlighting the critical need for effective procedural tools.

One significant challenge hampering market expansion is the stringent regulatory environment governing medical device approval. Manufacturers must navigate complex compliance requirements and rigorous safety standards which can significantly increase development costs and prolong the time required to bring new products to market. These regulatory hurdles often create barriers to entry for smaller companies and may slow the commercialization of innovative sheath technologies.

Key Market Drivers

The surge in demand for large-bore sheaths in structural heart procedures is a primary force propelling the Global Catheter Introducer Sheaths Market. As transcatheter therapies expand beyond aortic valve replacement to encompass complex mitral and tricuspid interventions, the need for specialized, high-performance access devices has intensified significantly. These advanced procedures require sheaths with larger inner diameters to accommodate sophisticated delivery systems while maintaining a low profile to minimize vascular complications and facilitate safe closure. This trend is clearly reflected in the rapid commercial growth of the structural heart segment. According to Edwards Lifesciences, July 2024, in the 'Second Quarter Results', Transcatheter Mitral and Tricuspid Therapies (TMTT) sales grew 75% compared to the prior year, underscoring the exploding adoption of these catheter-based interventions and the requisite access technologies.

Technological innovations in sheath design and biocompatible materials are further accelerating market expansion by enabling more complex procedures and improving patient safety profiles. Manufacturers are increasingly developing sheaths with advanced hydrophilic coatings, kink-resistant braiding, and steerable tips to navigate tortuous anatomy, particularly for electrophysiology and neurovascular applications. The commercial success of these next-generation technologies is driving substantial revenue gains for key industry players. According to Boston Scientific, February 2025, in the 'Q4 2024 Financial & Operational Highlights', the company's Electrophysiology segment grew 139% organically in 2024, largely fueled by the launch of the FARAPULSE Pulsed Field Ablation System. This innovation-led growth is supported by robust procedural volumes across the broader sector; according to Medtronic, May 2024, in fiscal year 2024, the Cardiovascular Portfolio generated $11.8 billion in revenue, reflecting the sustained, high-volume demand for interventional tools globally.

Download Free Sample Report

Key Market Challenges

The stringent regulatory environment governing medical device approval acts as a substantial impediment to the growth of the Global Catheter Introducer Sheaths Market. Manufacturers are compelled to navigate complex compliance frameworks and rigorous safety standards, which necessitate comprehensive clinical trials and exhaustive documentation. These mandatory procedures significantly extend the product development lifecycle, preventing companies from capitalizing on immediate market demands for advanced vascular access tools. The prolonged time required to secure regulatory clearance creates a bottleneck, causing a considerable lag between the conceptualization of innovative sheath technologies and their commercial availability to healthcare providers.

These regulatory hurdles impose a severe financial burden that restricts market entry and expansion. The high costs associated with compliance effectively exclude smaller enterprises that lack the capital to sustain operations during lengthy approval phases, thereby reducing overall market competition. The magnitude of this financial impact is evident in recent industry findings. According to MedTech Europe, in 2024, certification and maintenance costs under the Medical Device Regulation escalated up to 100% compared to previous directives. This dramatic increase in operational expenses forces manufacturers to divert critical funds away from research and development, directly stalling the introduction of new products and slowing the overall market growth rate.

Key Market Trends

Market players are extensively tailoring vascular access portfolios to meet the operational needs of Ambulatory Surgical Centers (ASCs). This migration is driven by the demonstrated safety of performing complex interventions in outpatient settings and reimbursement policies encouraging cost-effective care. The shift necessitates introducer sheaths that ensure rapid hemostasis and faster patient turnaround, which are critical metrics for ASC profitability. This structural change supports sustained volume growth; according to the Society for Cardiovascular Angiography & Interventions (SCAI), May 2025, in the 'Nationwide Study Finds Ambulatory Surgery Centers Treat 15% More Patients in Socially Vulnerable Areas for Cardiac Interventions', ASC volume is anticipated to increase by 21% between 2024 and 2034.

Simultaneously, the market is undergoing a decisive transition toward transradial access (TRA) for vascular interventions to reduce bleeding complications and facilitate early ambulation. This trend compels manufacturers to engineer radial-specific sheaths with thinner walls and optimized hydrophilic coatings that minimize spasm in smaller arteries. This approach is integral to the industry's push for same-day discharge protocols, further influencing product design. The adoption scale is significant; according to TCTMD, July 2025, in the article 'Most PCIs in US Now Done With Radial Access', the utilization of radial access for percutaneous coronary interventions in the U.S. reached 57.5%, confirming it as the dominant access strategy.

Segmental Insights

The Integrated Introducer Sheaths segment is positioned as the fastest-growing category within the Global Catheter Introducer Sheaths Market. This rapid expansion is primarily driven by the rising clinical adoption of transradial access for interventional procedures, which requires devices that minimize trauma to smaller vessels. Integrated sheaths feature a streamlined design that reduces the outer diameter while maintaining lumen capacity, effectively lowering the risks of radial artery occlusion and insertion-site bleeding. Consequently, healthcare providers increasingly utilize these devices to improve procedural safety and expedite patient ambulation, thereby sustaining high demand for this segment.

Regional Insights

North America maintains a leading position in the global catheter introducer sheaths market due to the rising incidence of cardiovascular diseases and a well-developed healthcare infrastructure. The region benefits from favourable reimbursement policies and a high rate of minimally invasive procedure adoption. Furthermore, the presence of key industry players in the United States ensures consistent product availability. Regulatory oversight by the U.S. Food and Drug Administration (FDA) supports market stability through established approval pathways. These factors collectively substantiate North America's dominance in the global market landscape.

Recent Developments

• In August 2025, Merit Medical Systems, Inc. released the Prelude Wave Hydrophilic Sheath Introducer featuring SnapFix Securement Technology in the United States market. This next-generation device was developed to address clinical challenges associated with radial access procedures, such as arterial spasm and occlusion. The sheath incorporated a hydrophilic coating and a low-profile design that required significantly less insertion force compared to competitor devices. The integrated securement technology was engineered to stabilize the sheath more effectively during interventions, aiming to improve procedural efficiency and patient comfort by reducing the likelihood of common vascular access complications.
• In March 2025, Inari Medical announced the release of the Artix Thrombectomy System, a solution purpose-built for the peripheral arterial system that included a specialized catheter introducer component. The system featured an 8 French, low-profile, trackable, and kink-resistant sheath available in multiple lengths to expand treatment options for complex and distal interventions. This launch represented the company's inaugural entry into the arterial space, providing a toolkit that combined aspiration and mechanical thrombectomy capabilities. The comprehensive system was designed to address acute to chronic clots while minimizing the risk of arterial clot migration through features like a covered nitinol mesh funnel.
• In January 2025, Penumbra, Inc. launched the Element Vascular Access System, which was described as the first laser-cut hypotube sheath specifically engineered for venous thromboembolism applications. The system was designed to provide foundational support and precise control during procedures, featuring a dual-valve engineering solution known as the HemoLock Valve System to ensure effective hemostasis. The device included a 17 French MaxID technology that enabled in-case visualization and was optimized for use with the company’s advanced mechanical thrombectomy systems. This launch aimed to enhance performance across challenging anatomies by maintaining stepwise support and improving trackability without the need for proximal hydrophilic coatings.
• In September 2024, Argon Medical Devices announced the commercial launch of a new vascular access device known as the Intara Introducer Sheath. This product was designed to facilitate the introduction of diagnostic and therapeutic devices into a patient's central or peripheral vasculature, specifically excluding the neuro and coronary vasculature. The 10-French sheath featured a kink-resistant design and enhanced visibility to assist medical professionals during navigation and delivery in complex procedures. The company anticipated that this device would support the usage of its transvenous liver biopsy systems and portal vein access sets, offering improved resilience and safety during interventions such as transjugular intrahepatic portosystemic shunt procedures.

Key Market Players

• Terumo Corporation
• Merit Medical Systems, Inc.
• Medtronic plc
• Galt Medical Corporation
• Cordis Corporation
• Oscor Inc
• Abbott Laboratories
• Stryker Corporation
• Becton, Dickinson and Company
• B. Braun Interventional Systems Inc

By Product	By End user	By Region
Integrated Introducer Sheaths Separable Introducer Sheaths	Hospitals & Clinics Ambulatory Care Centers Others	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Catheter Introducer Sheaths Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Catheter Introducer Sheaths Market, By Product:

• Integrated Introducer Sheaths
• Separable Introducer Sheaths

• Catheter Introducer Sheaths Market, By End user:

• Hospitals & Clinics
• Ambulatory Care Centers
• Others

• Catheter Introducer Sheaths Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE